due to deficiency of lipoprotein lipase. SLx-4090 by University of Texas South Western Medical
center is in phase 2 to study its effectiveness in combination with Orlistat. SLx-4090 is used to
treat high blood fat level mostly observed in hyperlipoproteinemia type 1 patients.
Rising prevalence of obesity is expected to fuel orlistat market growth. According to a survey
conducted by National Family Health Survey in 2015, in India, over 9.8 million men and over
20 million women were recorded to be obese. India stands second-highest in the world for
obese children, with the number constantly increasing by 3-5 million patients every year.
Orlistat Market Regional Analysis:-
North America is expected to hold a dominant position in the global orlistat market, owing to
high prevalence of obesity in the region. According to a study conducted by National Institute
of Health in 2016, over 38% of adults aged 20 years and above are obese, over 17.2% of
children aged 7 years and above are obese, and over 30% of the population is considered to be
overweight in the U.S. According to a study conducted by World Health Organization, in 2015,
over 40 million children aged 5 years and above were overweight in the U.S. Thus, high
prevalence of obesity is expected to fuel North America Orlistat market growth over the forecast
period.
Europe Orlistat market is expected to show significant growth due to expected launch of new
generic version of Orlistat over the forecast period. For instance, in 2011, Teva Pharmaceutical
Industries Ltd., launched generic version of Xenical Capsules in the U.K., which was
manufactured by Roche Holding AG. Xenical Capsules is used for the treatment of obesity as
well as for those whose BMI is greater than or equal to 30kg/m 2 and overweight patients. This
in turn, is expected to boost Orlistat market growth, as the drug seems more affordable thus,
being accessible to a large pool of patients.
Report includes chapters which deeply display the following deliverable about industry :
• Orlistat Market Research Objective and Assumption
• Orlistat Market Purview - Report Description, Executive Summary, and Coherent Opportunity
Map (COM)
• Orlistat Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory
Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain
Analysis, Porter’s Analysis, and PEST Analysis
• Global Orlistat Market, By Regions
• Orlistat Market Competition by Manufacturers including Production, Share, Revenue, Average
Price, Manufacturing Base Distribution, Sales Area and Product Type.